智通财经APP讯，耀皮玻璃(600819.SH)发布公告，中国复材依据自身战略规划和经营发展，聚焦复合 材料主责主业的需要，计划于公告发布之日起15个交易日后的3个月内，计划以集中竞价方式减持公司 股份不超过934.92万股(即不超过公司股份总数的1%)，以大宗交易方式减持公司股份不超过1179.78万股 (即不超过公司股份总数的1.2619%)。拟减持期间为2025年12月16日至2026年3月15日。减持价格按市场 价格确定。 ...

人民财讯11月24日电，耀皮玻璃（600819）11月24日公告，持股10%的股东中国复材拟减持公司股份不 超过2.26%。 ...

耀皮玻璃（600819）(600819.SH)发布公告，中国复材依据自身战略规划和经营发展，聚焦复合材料主 责主业的需要，计划于公告发布之日起15个交易日后的3个月内，计划以集中竞价方式减持公司股份不 超过934.92万股(即不超过公司股份总数的1%)，以大宗交易方式减持公司股份不超过1179.78万股(即不 超过公司股份总数的1.2619%)。拟减持期间为2025年12月16日至2026年3月15日。减持价格按市场价格 确定。 ...

Market Overview - The glass and fiberglass sector experienced a decline of 0.84% on November 24, with China National Materials Technology leading the drop [1] - The Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1] Stock Performance - Notable gainers in the glass and fiberglass sector included: - Honghe Technology (603256) with a closing price of 29.02, up 3.09% on a trading volume of 128,500 shares and a turnover of 369 million yuan [1] - International Composites (301526) closed at 5.54, up 2.21% with a trading volume of 287,400 shares and a turnover of 158 million yuan [1] - Major decliners included: - China National Materials Technology (002080) which closed at 29.67, down 4.44% with a trading volume of 480,800 shares and a turnover of 1.456 billion yuan [2] - Jinjing Technology (600586) closed at 5.56, down 3.64% with a trading volume of 417,800 shares and a turnover of 235 million yuan [2] Capital Flow - The glass and fiberglass sector saw a net outflow of 133 million yuan from institutional investors, while retail investors contributed a net inflow of 207 million yuan [2] - The detailed capital flow for selected stocks showed: - South Glass A (000012) had a net inflow of 13.57 million yuan from institutional investors [3] - China National Materials Technology (600176) experienced a net outflow of 23.08 million yuan from speculative funds [3]

Core Viewpoint - Yao Pi Glass has received approval from the China Securities Regulatory Commission (CSRC) for a specific stock issuance, aiming to raise up to 300 million yuan for energy upgrades and working capital [2][4]. Group 1: Stock Performance - As of November 21, 2025, Yao Pi Glass closed at 8.6 yuan, down 8.9% from the previous week's 9.44 yuan [1]. - The stock reached a weekly high of 9.64 yuan on November 18 and a low of 8.33 yuan on November 21 [1]. - The company's current total market capitalization is 8.04 billion yuan, ranking 8th in the glass fiber sector and 2177th in the A-share market [1]. Group 2: Company Announcements - Yao Pi Glass has received the CSRC's approval for its application to issue stocks to specific investors, valid for 12 months from the date of approval [2]. - The company plans to raise a total of no more than 300 million yuan through this issuance, which will be allocated for energy upgrades and automation projects, as well as to supplement working capital [2][4]. - The issuance will target no more than 35 qualified specific investors, with the issuance price set at no less than 80% of the average trading price over the previous 20 trading days [2].

股票简称：耀皮玻璃/耀皮 B 股 股票代码：600819/900918 （中国（上海）自由贸易试验区张东路 1388 号 4-5 幢） 上海耀皮玻璃集团股份有限公司 2025 年度向特定对象发行 A 股股票 募集说明书 （注册稿） 保荐人（主承销商） 二〇二五年十一月 上海耀皮玻璃集团股份有限公司 募集说明书 声 明 1、本公司及全体董事、高级管理人员承诺募集说明书及其他信息披露资料 不存在任何虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性及完整 性承担相应的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中 财务会计资料真实、准确、完整。 3、本募集说明书按照《上市公司证券发行注册管理办法》《公开发行证券 的公司信息披露内容与格式准则第 61 号——上市公司向特定对象发行证券募集 说明书和发行情况报告书》等要求编制。 4、中国证监会、上海证券交易所对本次发行所作的任何决定或意见，均不 表明其对申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 5、根据《 ...

Core Points - The company has received approval from the China Securities Regulatory Commission (CSRC) for the registration of a stock issuance to specific investors [1][2] - The approval is valid for 12 months from the date of registration [2] - The company is required to report any significant events to the Shanghai Stock Exchange before the completion of the stock issuance [2] Summary by Sections - **Approval Details** - The CSRC has granted approval for the company to issue stocks to specific investors [1] - The issuance must be conducted in accordance with the submitted documents and issuance plan [1] - **Regulatory Compliance** - The company must adhere to relevant laws and regulations as well as the authorization from the shareholders' meeting [2] - The company is obligated to fulfill information disclosure duties in a timely manner [2]

Core Viewpoint - Yao Pi Glass has received approval from the China Securities Regulatory Commission for a specific stock issuance, which is valid for 12 months from the date of approval [1][2]. Group 1: Stock Performance - As of November 19, 2025, Yao Pi Glass closed at 8.86 yuan, down 4.53% from the previous trading day [1]. - The stock opened at 9.19 yuan, reached a high of 9.6 yuan, and a low of 8.63 yuan, with a trading volume of 2.3 billion yuan and a turnover rate of 3.42% [1]. Group 2: Regulatory Approval - The company has received the approval notice (Document No. 2520) from the China Securities Regulatory Commission for the registration of stock issuance to specific investors [1]. - The company is required to strictly follow the submitted documents and issuance plan during the issuance process and must report any significant events in a timely manner [1]. - The board of directors will handle related matters within the specified timeframe and fulfill information disclosure obligations as per the approval requirements [1].

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for a stock issuance to specific targets, which is a significant step for its capital raising efforts [1] Group 1 - The company is authorized to issue stocks to specific targets as per the approval from the regulatory body [1] - The approval is valid for 12 months from the date of registration [1] - The company must adhere to the submitted documents and issuance plan during the stock issuance process [1]